Astrazeneca Pharma India Ltd.

Market Capital
₹8,322 Cr.
P/E
75.65
Share Price
₹ 3562.45 218.65 (6.54%)

Astrazeneca Pharma India Ltd.

Quick View
₹ 3562.45 218.65 (6.54%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Share price
Share price has increased over last 10 years but more due to rerating
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been selling the stock which is usually a good time to buy
ROE
Latest
12.05%
3yr Average
17.44%
5yr Average
16.18%
Net Profit Margin
Latest
7.65%
3yr Average
9.27%
5yr Average
7.96%
ROCE
Latest
14.36%
3yr Average
22.71%
5yr Average
20.57%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
1.42% (as of Jul 22)
Anti - Diabetes - Market Share
0% (as of Jul 22)
Anti-Infectives - Market Share
1.71% (as of Nov 21)
Antineo Plastic - Market Share
0.56% (as of May 19)
Blood Related - Market Share
1.73% (as of Jul 22)
Cardiovascular - Market Share
0.94% (as of Nov 21)
Endocrinology - Market Share
0% (as of Jul 22)
Gastro-Intestinal - Market Share
0.45% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.11% (as of Nov 21)
Respiratory - Market Share
1.96% (as of May 19)
Stomatological - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Dosage Form Break-Up

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up -Oncology

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Crestor
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Astrazeneca Pharma India Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    How The Pharma Industry Works - PPFAS
    timeline
    Sign Up for Free